Filter News

CPRIT funds study of drug resistance in glioblastomas

December 7, 2012

Studies of how to overcome drug resistance in deadly central nervous system tumors called glioblastomas will propel forward thanks to $755,718 from the Cancer Prevention & Research Institute of Texas.

UT Health Science Center San Antonio spin-out company Rapamycin Holdings licenses drug’s intellectual property

December 7, 2012

The ability of rapamycin-related drugs to potentially slow the aging process — suggested in animal experiments at The University of Texas Health Science Center San Antonio — has led to establishment of a new San Antonio biotech company, Rapamycin Holdings Inc., which is licensing exclusive rights to intellectual property central to several aspects of the rapamycin-related drugs.

Study: Newer technology improves detection of stillbirth cause

December 6, 2012

A tool called microarray testing can help doctors to more often pinpoint the potential genetic reason for a stillbirth, so that more couples can learn what happened to their babies, a study of 500 stillbirths in San Antonio and four other cities showed.

M.D./Ph.D. students, Baptist nursing students celebrate Adler family’s gift of $1.5 million

December 6, 2012

Doctoral students, nursing students, and officials of the UT Health Science Center San Antonio and the Baptist Health Foundation of San Antonio are celebrating $1.5 million in gifts from the estate of Laura A. Adler in memory of her husband, Harry F. Adler, M.D., Ph.D.

Leaders to announce licensing of UT Health Science Center intellectual property to Rapamycin Holdings Inc.

December 5, 2012

etails concerning the licensing of rapamycin-related intellectual property developed at the UT Health Science Center San Antonio to an emerging spin-out company, Rapamycin Holdings Inc. Rapamycin, a drug federally approved to suppress organ rejection, continues to be studied for its potential to slow the aging process and its efficacy in treating age-related diseases.

San Antonio Breast Cancer Symposium begins today

December 4, 2012

The 35th annual CTRC-AACR San Antonio Breast Cancer Symposium, where close to 7,500 researchers, clinicians and advocates from around the world are gathering to present and hear about the latest research, trends and topics of discussion in breast cancer, including drug trials and treatment methods.

Free lecture to help understand your PSA results

December 1, 2012

In a free Dec. 8 public lecture, Ian M. Thompson Jr., M.D., will discuss the latest information in prostate cancer prevention and treatment.

San Antonio Breast Cancer Symposium to tackle latest issues in research and treatment next week

November 29, 2012

Close to 7,500 researchers, clinicians and advocates will gather here next week at one of the largest breast cancer symposiums in the world.

Winter Texan honored with memorial portrait on Donate Life float in 2013 Rose Parade

November 28, 2012

Tissue donor’s husband to complete floragraph at Wednesday, Dec. 5, event in Edinburg

UT Medicine cardiologist uses TAVR procedure to return quality of life to New Mexico man

November 16, 2012

FDA expands approved use of artificial heart valve to more patients

Filter news